- $34.33m
- $16.37m
- $150.36m
- 76
- 89
- 51
- 83
C2019 June 30th | C2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 64.9 | 89.4 | 126 | 152 | 150 |
Cost of Revenue | |||||
Gross Profit | 23.8 | 31.1 | 40.2 | 41 | 34.5 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 68 | 86.2 | 118 | 145 | 150 |
Operating Profit | -3.09 | 3.21 | 8.38 | 7.41 | 0.076 |
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -3.1 | 3.71 | 8.32 | 7.68 | 0.77 |
Provision for Income Taxes | |||||
Net Income After Taxes | -3.29 | 2.87 | 7.06 | 4.64 | 0.095 |
Minority Interest | |||||
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -3.27 | 2.94 | 6.82 | 4.46 | 0.193 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -3.27 | 2.94 | 6.82 | 4.46 | 0.193 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.236 | 0.2 | 0.388 | 0.212 | 0.075 |
Special Dividends per Share |